Nivolumab With DC Vaccines for Recurrent Brain Tumors
Clinical trial NCT02529072 · COMPLETED
Trial details
- NCT number
- NCT02529072
- Sponsor
- Gary Archer Ph.D.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2017-09-15
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.